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BACKGROUND

OBJECTIVES
To
understand
the
demographic
characteristics of Hepatitis-‐B infected
mothers residing in Houston and Harris
County who have been case managed by
the PBHPP. The findings of this project will
enhance the case-‐management strategies
employed by the HHD to prevent the
transmission of mother-‐to-‐child Hepatitis B.
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CONCLUSIONS
Though the Houston PHBPP PVST completion
rates are improving, targeted interventions
are needed to focus on increasing the PVST
completion rates amongst the API and Black,
non-‐Hispanic groups. Further analysis will be
conducted on the 39 infants who have
unknown immunity, to fully understand the
Houston PHBPP program practices and the
factors that affect PVST completion among
different racial and ethnic groups. The HHD
will continue to work on improving their
case-‐management services and increasing
the PVST completion rate among infants,
who are at risk.
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Infants born in 2015 to hepatitis B-‐
infected
women
living
in
Houston/Harris County, and case-‐
managed by Houston PHBPP were
exported from the HHD surveillance
system. Maternal race/ethnicity was
analyzed for infants who were
immune to understand if it
influenced PVST completion.

Percentage

Hepatitis B virus (HBV) is a serious blood-‐
borne viral infection and can lead to
premature death from hepatocellular
carcinoma. 1 A chronically infected patient
remains a host for HBV transmission.
Pregnant women with chronic HBV pose a
serious threat to their infants; hence, post-‐
exposure immunoprophylaxis is necessary.
In accordance to the Center of Disease
Control (CDC) recommendations, infants
born to HBV infected women should
complete PVST between 9-‐18 months of age
2 Post-‐Vaccination Serological Testing (PVST)
is also recommended to test an infant's
immune response to the HBV vaccinations.
The Perinatal Hepatitis B Prevention
Program (PBHPP) aims to prevent
transmission of HBV from infected mothers
to babies born in the United States.
Although, the majority of cases can be
traced to the Western Pacific and African
regions 3, there is limited knowledge on
factors that affect PVST completion among
cases managed by the Houston Health
Department (HHD). This project aims to
assess the PVST completion rates among
infants born between January 1, 2015 to
December 31, 2015 to HBV-‐positive mothers
managed by HHD.

METHODS

Unkwown

After analysis of the 232 infants case-‐managed
by the program, 64 infants were excluded. Of
the 168 infants eligible for PVST, 76% (n=129)
have completed PVST; 84.5% (n=109) infants
completed PVST within the recommended
interval and 15.5% (n=20) completed PVST after
18 months of age. 54.2% (n=70) are
Asian/Pacific Islander (API), 29.5% (n=38) are
Black Non-‐Hispanic, 7% (n=9) are White
Hispanic, 6.2% (n=8) are White non-‐Hispanic,
and 3.1% (n=4) are of unknown ethnicity. Of the
39 eligible infants who did not complete PVST,
38% (n=15) are API, 33% (n=13) are Black non-‐
Hispanic, 15% (n=6) are White Hispanic, 8%
(n=3) are White non-‐Hispanic, and 5% (n=2) are
of unknown race/ethnicity.
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